OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19
Homa Nath Sharma, Charity O. D. Latimore, Qiana L. Matthews
Pathogens (2021) Vol. 10, Iss. 9, pp. 1218-1218
Open Access | Times Cited: 8
Homa Nath Sharma, Charity O. D. Latimore, Qiana L. Matthews
Pathogens (2021) Vol. 10, Iss. 9, pp. 1218-1218
Open Access | Times Cited: 8
Showing 8 citing articles:
A SARS-CoV-2: Companion Animal Transmission and Variants Classification
Rachana Pandit, Qiana L. Matthews
Pathogens (2023) Vol. 12, Iss. 6, pp. 775-775
Open Access | Times Cited: 7
Rachana Pandit, Qiana L. Matthews
Pathogens (2023) Vol. 12, Iss. 6, pp. 775-775
Open Access | Times Cited: 7
Targeting host inducible-heat shock protein 70 with PES-Cl is a promising antiviral strategy against SARS-CoV-2 infection and pathogenesis
Prerna Joshi, Swati Garg, Shailendra Mani, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135069-135069
Closed Access | Times Cited: 1
Prerna Joshi, Swati Garg, Shailendra Mani, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135069-135069
Closed Access | Times Cited: 1
SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far
Carmelo Biondo, Angelina Midiri, Elisabetta Gerace, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2087-2087
Open Access | Times Cited: 6
Carmelo Biondo, Angelina Midiri, Elisabetta Gerace, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2087-2087
Open Access | Times Cited: 6
COVID-19: Perspectives on innate immune evasion
Alaa A. A. Aljabali, Mohamed El‐Tanani, Debmalya Barh, et al.
Progress in molecular biology and translational science (2024)
Closed Access
Alaa A. A. Aljabali, Mohamed El‐Tanani, Debmalya Barh, et al.
Progress in molecular biology and translational science (2024)
Closed Access
Interferon therapy in alpha and Delta variants of SARS-CoV-2: The dichotomy between laboratory success and clinical realities
Atefe Alirezaee, Milad Mirmoghtadaei, Hanieh Heydarlou, et al.
Cytokine (2024) Vol. 186, pp. 156829-156829
Closed Access
Atefe Alirezaee, Milad Mirmoghtadaei, Hanieh Heydarlou, et al.
Cytokine (2024) Vol. 186, pp. 156829-156829
Closed Access
Diversity in the Clinical Course and Outcome of COVID-19 in Patients with Different Inborn Errors of Immunity can be Associated with the Type of Error
Negin Salemi, Behrokh Shojaie, Paria Bolourinejad, et al.
Advanced Biomedical Research (2024) Vol. 13, Iss. 1
Open Access
Negin Salemi, Behrokh Shojaie, Paria Bolourinejad, et al.
Advanced Biomedical Research (2024) Vol. 13, Iss. 1
Open Access
Integrative multi-omics analysis to gain new insights into COVID-19
Setegn Eshetie, Karmel W. Choi, Elina Hyppönen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Setegn Eshetie, Karmel W. Choi, Elina Hyppönen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Plasma gp96 is a Novel Predictive Biomarker for Severe COVID-19
Rongguo Wei, Biyan Zhou, Shaohua Li, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 2
Rongguo Wei, Biyan Zhou, Shaohua Li, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 2
